Study finds low pain in breast cancer patients treated with palbociclib

Patients with advanced/unresectable or metastatic breast cancer treated with palbociclib combination therapy experienced low levels of baseline pain and fatigue, a recent study found. The study is apparently one of the first outside a clinical […]

View more

Sexual health best practices for physicians of female patients with cancer

Sexual health is important for any adult’s well-being, but patients with cancer face a new set of challenges when it comes to sexuality. Laila S. Agrawal, M.D., breast cancer oncologist with Norton Cancer Institute, is […]

View more

FDA approves non-chemotherapy drug regimen for acute myeloid leukemia

The Food and Drug Administration (FDA) recently approved Venclexta (venetoclax) as part of a non-chemotherapy treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude […]

View more

Diffuse midline glioma: A review of treatments for hydrocephalus

A review of patients with midline tumors suggests shunting may be a more robust treatment for hydrocephalus in pediatric and adult patients with diffuse midline gliomas. Charts of 43 consecutive midline tumor patients were reviewed […]

View more

Neuro-oncologist brings mix of research experience, passion for physician-patient relationship

As a neuro-oncologist with Norton Cancer Institute, Kaylyn Sinicrope, M.D., treats brain tumors and other neurological conditions related to cancer. Dr. Sinicrope said she was attracted to oncology by the deep doctor-patient relationships that are […]

View more

Cancer evaluation and diagnostic center opens on West Hill Street

Differentiating cancer from other unexplained masses, lumps or abnormalities can be quite complicated. It hinges on access to state-of-the-art testing, knowledgeable specialists who can make the right referral and follow-up, plus effective ongoing care. Norton […]

View more

Register now for the Garlove Lectureship — Lynch syndrome

The 25th Gail Klein Garlove Lectureship will be held by video conference this year, discussing “Lynch Syndrome and Lessons About Hereditary Cancer Syndromes.” The deadline to register for the Nov. 11 event is Friday, Nov. […]

View more

John T. Hamm, M.D., named chair for American Society of Clinical Oncology’s Quality of Care Council

John T. Hamm, M.D., director of Norton Cancer Institute’s research program and chairman of the Norton Hospital Cancer Committee, will lead the Quality of Care Council of the American Society of Clinical Oncology (ASCO). The […]

View more

Updates on colon cancer screening, including patients with a family history

The latest colon cancer screening recommendations call for earlier screenings and include guidance to better reflect individual risks. The starting age for screening for the average person with no risk factors is now 45, five […]

View more

Norton Healthcare expands COVID-19 experimental treatments

As patients continue to be diagnosed with COVID-19, the disease caused by the coronavirus, Norton Healthcare is looking for ways to help them overcome the infection. Norton Healthcare is the first in the world to […]

View more

Multidisciplinary work drives robust research program

Clinical trials are vital tools in our fight against cancer. These have become an important link in determining the best new treatments and how therapies are best administered. In 2019, Norton Cancer Institute offered nearly […]

View more

New space for growing Head and Neck Tumor Program

As part of Norton Cancer Institute’s major renovation of its downtown location, the building’s second floor has been remodeled to expand access to the Head and Neck Tumor Program. The expansion optimizes the program’s ability […]

View more

Search our entire site.